0.3055
Cardio Diagnostics Holdings Inc stock is traded at $0.3055, with a volume of 1.34M.
It is down -7.31% in the last 24 hours and down -27.09% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
See More
Previous Close:
$0.3296
Open:
$0.32
24h Volume:
1.34M
Relative Volume:
0.62
Market Cap:
$15.93M
Revenue:
-
Net Income/Loss:
$-9.37M
P/E Ratio:
-0.3358
EPS:
-0.9099
Net Cash Flow:
$-7.34M
1W Performance:
-19.56%
1M Performance:
-27.09%
6M Performance:
+35.36%
1Y Performance:
-74.75%
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CDIO
Cardio Diagnostics Holdings Inc
|
0.3055 | 15.93M | 0 | -9.37M | -7.34M | -0.9099 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Cardio Diagnostics (CDIO) Projected to Post Quarterly Earnings on Monday - Defense World
BG Medicine (OTCMKTS:BGMD) & Cardio Diagnostics (NASDAQ:CDIO) Financial Review - The AM Reporter
Contrasting Cardio Diagnostics (NASDAQ:CDIO) & BG Medicine (OTCMKTS:BGMD) - Defense World
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session - BioSpace
Game-Changing Blood Test Outperforms Traditional Heart Disease Detection Methods - Stock Titan
Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cardio Diagnostics Holdings Inc. (CDIO) reports earnings - Quartz
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week - Business Wire
Trade Show Breaking News and Press Releases - Business Wire
Is Cardio Diagnostics Holdings, Inc. (CDIO) The Best Day Trading Stock To Invest In Now? - Insider Monkey
10 Best Day Trading Stocks To Invest In Now - Insider Monkey
Cardio Diagnostics Unveils Strategic Vision for Future Growth - TipRanks
This morning’s top pick is Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) - US Post News
Potential Price Increase for Cardio Diagnostics Holdings Inc (CDIO) After Recent Insider Activity - Knox Daily
Cardio Diagnostics Holdings Inc (CDIO) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Cardio Diagnostics Holdings Inc (CDIO) Stock: A Closer Look at the Market Potential - The News Heater
A Look at Cardio Diagnostics Holdings Inc (CDIO) Shares in the Recent Past Indicates Growth - SETE News
Unlocking AI: Is Cardio Diagnostics Holdings the Next Big Thing? - Jomfruland.net
Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships - Insider Monkey
Cardio Diagnostics Holdings Inc (CDIO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Cardio Diagnostics Holdings Inc (CDIO) presents a great opportunity, but the stock is slightly undervalued - US Post News
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations - Business Wire
AI-Powered Heart Disease Testing Breakthrough: Cardio Diagnostics Signs 7 Strategic Healthcare Alliances - Stock Titan
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - br.ADVFN.com
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) Is A Buzzing Hot Stock - Stocks Register
Heart Attack Diagnostics Market Booms with AI, Biomarkers, and Cutting-Edge Imaging TechnologiesMarket Set to Surge from $11.68 Billion in 2024 to $27.95 Billion by 2035 - GlobeNewswire
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - Asianet Newsable
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests - Yahoo Finance
Cardio Diagnostics Secures Medicare Coverage Path for AI-Powered Heart Disease Tests - StockTitan
Cardio Diagnostics files to sell 1.23M shares of common stocks by selling shareholders - MSN
Cardio Diagnostics granted extension to regain Nasdaq compliance - Investing.com
Cardiovascular Devices Market Growth Driven by Innovations in Diagnosis and Treatment - openPR
Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2024Forecast, Trends - WhaTech
Heart Attack Diagnostic Market Size, Share, Trend Analysis, Segmentation And Forecast To 2033 - openPR
Heart Attack Diagnostics Market: What Represents The Key Growth - openPR
Cardio Diagnostics shareholders approve key proposals - Investing.com India
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Cardiovascular Monitoring & Diagnostic Devices Market 2024-2033Size, Trends & Competitive Analysis - openPR
CDIOCardio Diagnostics Holdings Inc Latest Stock News & Market Updates - StockTitan
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference - Yahoo Finance
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Analysts Provide Their Views On Cardio Diagnostics Holdings Inc (CDIO) - Stocks Register
In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Size, Trends And Overview 2024-2033 - openPR
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Direxion Daily NVDA Bull 2X Shares (NASDAQ:NVDU) Short Interest Down 38.4% in October - Defense World
Zanaga Iron Ore (LON:ZIOC) Stock Price Down 11.1% – Time to Sell? - Defense World
Cardiovascular Devices Market Size, Trends, Growth, - openPR
Is Cardio Diagnostics Holdings Inc (CDIO) worth investing in despite its overvalued state? - US Post News
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):